ANI Pharmaceuticals, Inc. (ANIP) by event type

ANIP moves most on analyst downgrades — a median of +0.54% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ANIP overview →

By event type

How ANIP reacts across 4 measured event types.

EventEventsMedian 30-min% positiveMedian to close
Analyst downgrades
361 of 2,603
10+0.54%80%+1.60%
Coverage initiations
605 of 2,283
25+0.29%56%-0.30%
Rating reiterations
230 of 3,522
44+0.38%66%-0.05%
Price-target raises
1,591 of 1,790
16-0.23%44%-0.77%

Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.

That’s how ANIP usually reacts — get an email when it moves on news →
Keep exploring

Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · ANIP overview →

Other Healthcare names, measured the same way

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.